Peer-influenced content. Sources you trust. No registration required. This is HCN.

Journal of Neurology, Neurosurgery & PsychiatryCognitive and Neuropsychiatric Effects of Noradrenergic Treatment in Alzheimer’s Disease: Systematic Review and Meta-Analysis

As this review discovered, repurposing of established noradrenergic drugs is most likely to offer effective treatment in Alzheimer’s disease for general cognition and apathy. Still, the report offers several factors that should be considered before designing future clinical trials.

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form